Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells

Bok Yun Kang, Eugene Kim, Tae Sung Kim

Research output: Contribution to journalReview article

40 Citations (Scopus)

Abstract

Studies with neutralizing anti-interleukin (IL)-12 antibodies and IL-12-deficient mice have suggested that endogenous IL-12 plays an important role in the normal host defense against infection by a variety of intracellular microorganisms. However, IL-12 also appears to play a central role in the pathogenesis of autoimmune diseases such as multiple sclerosis or rheumatic arthritis. Therefore, it is crucial to understand how IL-12 is produced and its production is regulated at the molecular level. IL-12 production is differentially regulated through multiple pathways, which can be classified as follows: nuclear factor-kappaB (NF-κB) and other transcription factors, p38 mitogen-activated protein (MAP) kinase, cyclic adenosine monophosphate (cyclic AMP)-modulating molecules, cell membrane ion channels and pumps, nitric oxide (NO), and receptors. In this review we describe the regulatory mechanisms of IL-12 production in immune cells and also some agents to control IL-12 production for the treatment of immune-related diseases.

Original languageEnglish
Pages (from-to)665-673
Number of pages9
JournalCellular Signalling
Volume17
Issue number6
DOIs
Publication statusPublished - 2005 Jun

Keywords

  • Diseases
  • IL-12
  • Immune
  • Regulation
  • Signalling
  • Therapeutic compounds

ASJC Scopus subject areas

  • Cell Biology

Fingerprint Dive into the research topics of 'Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells'. Together they form a unique fingerprint.

  • Cite this